DE69609772D1 - 3-Substituierte Oxindolderivate als Kaliumkanalmodulatoren - Google Patents
3-Substituierte Oxindolderivate als KaliumkanalmodulatorenInfo
- Publication number
- DE69609772D1 DE69609772D1 DE69609772T DE69609772T DE69609772D1 DE 69609772 D1 DE69609772 D1 DE 69609772D1 DE 69609772 T DE69609772 T DE 69609772T DE 69609772 T DE69609772 T DE 69609772T DE 69609772 D1 DE69609772 D1 DE 69609772D1
- Authority
- DE
- Germany
- Prior art keywords
- potassium channel
- channel modulators
- oxindole derivatives
- substituted oxindole
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/477,047 US5565483A (en) | 1995-06-07 | 1995-06-07 | 3-substituted oxindole derivatives as potassium channel modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69609772D1 true DE69609772D1 (de) | 2000-09-21 |
DE69609772T2 DE69609772T2 (de) | 2001-04-12 |
Family
ID=23894292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69609772T Expired - Lifetime DE69609772T2 (de) | 1995-06-07 | 1996-06-06 | 3-Substituierte Oxindolderivate als Kaliumkanalmodulatoren |
Country Status (26)
Country | Link |
---|---|
US (2) | US5565483A (de) |
EP (1) | EP0747354B1 (de) |
JP (1) | JP4011135B2 (de) |
KR (1) | KR100432157B1 (de) |
CN (1) | CN1076348C (de) |
AR (1) | AR004493A1 (de) |
AT (1) | ATE195515T1 (de) |
AU (1) | AU707760B2 (de) |
BR (1) | BR1100180A (de) |
CA (1) | CA2176183C (de) |
CZ (1) | CZ289248B6 (de) |
DE (1) | DE69609772T2 (de) |
DK (1) | DK0747354T3 (de) |
ES (1) | ES2148685T3 (de) |
GR (1) | GR3034523T3 (de) |
HK (1) | HK1003301A1 (de) |
HU (1) | HU222046B1 (de) |
IL (1) | IL118349A (de) |
NO (1) | NO304829B1 (de) |
NZ (1) | NZ286748A (de) |
PL (1) | PL184660B1 (de) |
PT (1) | PT747354E (de) |
RU (1) | RU2165925C2 (de) |
SG (1) | SG70572A1 (de) |
TW (1) | TW384284B (de) |
ZA (1) | ZA964327B (de) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW504504B (en) * | 1996-11-26 | 2002-10-01 | Bristol Myers Squibb Co | 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
HUP0002449A3 (en) * | 1997-05-30 | 2001-12-28 | Bristol Myers Squibb Company W | Process for producing 3-fluoro oxindole derivatives and intermediates of the preparation |
US5893085A (en) * | 1997-06-10 | 1999-04-06 | Phillips; Ronald W. | Dynamic fuzzy logic process for identifying objects in three-dimensional data |
US5972894A (en) * | 1997-08-07 | 1999-10-26 | Cytran, Inc. | Peptides having potassium channel opener activity |
US5972961A (en) * | 1997-08-28 | 1999-10-26 | Bristol-Myers Squibb Company | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
EP1105406A4 (de) * | 1998-08-14 | 2004-12-15 | Elan Pharm Inc | Esk-kaliumkanal-polypeptid und polynukleotidzusammensetzungen |
ATE285769T1 (de) * | 1998-12-04 | 2005-01-15 | Neurosearch As | Verwendung von isatinderivaten als ionenkanalaktivierende mittel |
RU2240998C2 (ru) * | 1998-12-04 | 2004-11-27 | Бристол-Маерс Сквибб Компани | Производные 3-замещенного 4-арилхинолин-2-она в качестве модуляторов калиевых каналов |
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
EP1198456B1 (de) * | 1999-08-03 | 2007-09-19 | Abbott Laboratories | Kalium kanalaktivatoren |
DE60124080T2 (de) * | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
US6992081B2 (en) | 2000-03-23 | 2006-01-31 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
EP1303269B1 (de) * | 2000-06-29 | 2005-12-07 | NeuroSearch A/S | Verwendung von 3-substituierten oxidinolderivaten als kcnq kaliumkanalmodulatoren |
ES2248356T3 (es) | 2000-06-30 | 2006-03-16 | Elan Pharmaceuticals, Inc. | Compuestos para tratar la enfermedad de alzheimer. |
PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
JP2004511457A (ja) * | 2000-10-13 | 2004-04-15 | ブリストル−マイヤーズ スクイブ カンパニー | 高い細胞内カルシウム濃度の条件下で機能する選択的マキシ−kカリウムチャネル・オープナー、その方法および用途 |
US6348486B1 (en) * | 2000-10-17 | 2002-02-19 | American Home Products Corporation | Methods for modulating bladder function |
US6469042B1 (en) * | 2001-02-20 | 2002-10-22 | Bristol-Myers Squibb Company | Fluoro oxindole derivatives as modulators if KCNQ potassium channels |
IL157313A0 (en) | 2001-02-20 | 2004-02-19 | Bristol Myers Squibb Co | Modulators of kcnq potassium channels and uses thereof |
CA2438805A1 (en) * | 2001-02-20 | 2002-08-29 | Bristol-Myers Squibb Company | Fluoro oxindole derivatives as modulators of kcnq potassium channels |
AR033095A1 (es) * | 2001-04-04 | 2003-12-03 | Wyeth Corp | Metodos para el tratamiento de motilidad gastrica hiperactiva |
BR0210721A (pt) * | 2001-06-27 | 2004-07-20 | Elan Pharm Inc | Composto, sal ou éster farmaceuticamente aceitável, método para fabricar um composto, e, método para tratar um paciente que tem, ou para evitar que o paciente adquira uma doença ou condição |
BR0308737A (pt) * | 2002-03-20 | 2005-01-11 | Bristol Myers Squibb Co | Pró-drogas de fosfato de fluoroxindóis |
AU2003240427A1 (en) * | 2002-06-26 | 2004-01-19 | Poseidon Pharmaceuticals A/S | Novel benzimidazol-2-one derivatives and their use |
TWI271402B (en) * | 2002-10-15 | 2007-01-21 | Tanabe Seiyaku Co | Large conductance calcium-activated K channel opener |
US7632866B2 (en) * | 2002-10-21 | 2009-12-15 | Ramot At Tel Aviv University | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
JP2006513154A (ja) * | 2002-10-21 | 2006-04-20 | ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド | カリウムチャネルおよび/または皮質ニューロン活性モジュレーターとしての、n−フェニルアントラニル酸および2−ベンズイミダゾロンの誘導体 |
KR100456679B1 (ko) * | 2002-11-14 | 2004-11-10 | 현대모비스 주식회사 | 차량의 조수석 에어백의 장착구조 |
US6916937B2 (en) * | 2003-02-03 | 2005-07-12 | Bristol-Myers Squibb Company | Carbohydrate prodrugs of fluorooxindoles |
TW200508197A (en) * | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
WO2005017105A2 (en) | 2003-06-17 | 2005-02-24 | California University Of Technology | Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
JP2007523873A (ja) * | 2003-07-15 | 2007-08-23 | スミスクライン・ビーチャム・コーポレイション | 新規化合物 |
WO2005035498A1 (ja) * | 2003-10-08 | 2005-04-21 | Dainippon Sumitomo Pharma Co., Ltd. | 含窒素二環性化合物の摂食調節剤としての用途 |
US7671072B2 (en) * | 2003-11-26 | 2010-03-02 | Pfizer Inc. | Aminopyrazole derivatives as GSK-3 inhibitors |
US7169803B2 (en) * | 2004-03-15 | 2007-01-30 | Bristol-Myers Squibb Company | N-substituted prodrugs of fluorooxindoles |
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
GT200500321A (es) | 2004-11-09 | 2006-09-04 | Compuestos y composiciones como inhibidores de proteina kinase. | |
HU0500126D0 (en) * | 2005-01-26 | 2005-04-28 | Sanofi Aventis | New compounds and process for their preparation |
HU0500157D0 (en) * | 2005-02-01 | 2005-04-28 | Sanofi Aventis | New compounds |
HUP0500167A2 (en) * | 2005-02-02 | 2007-03-28 | Sanofi Aventis | Optically active 4-chloro-3-(5-chloro-3-alkyl-2-oxo-2,3-dihydro-1h-indol-3-yl)benzoic acid derivatives and process for producing them |
CA2604759A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5-ht2c激动剂的用途 |
GT200600162A (es) * | 2005-04-24 | 2007-03-14 | Metodos para modular la funcion de la vejiga | |
US7576082B2 (en) * | 2005-06-24 | 2009-08-18 | Hoffman-La Roche Inc. | Oxindole derivatives |
AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
PA8720801A1 (es) * | 2006-03-24 | 2008-11-19 | Wyeth Corp | Nuevas combinaciones terapeuticas para el tratamiento de la depresion |
CN101410118A (zh) * | 2006-03-24 | 2009-04-15 | 惠氏公司 | 疼痛的治疗 |
CL2007000773A1 (es) * | 2006-03-24 | 2008-01-25 | Wyeth Corp | Uso de compuestos derivados de diazepina condensada para el tratamiento de un desorden cognitivo como add o adhd;o su uso para tratar spm o pmdd. |
US8026085B2 (en) * | 2006-08-04 | 2011-09-27 | California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
US8252559B2 (en) * | 2006-08-04 | 2012-08-28 | The California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
US8802401B2 (en) * | 2007-06-18 | 2014-08-12 | The California Institute Of Technology | Methods and compositions for preparation of selectively protected carbohydrates |
WO2009037707A2 (en) | 2007-09-20 | 2009-03-26 | Ramot At Tel Aviv University Ltd. | N-phenyl anthranilic acid derivatives and uses thereof |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
EP2205079A4 (de) * | 2007-10-04 | 2010-10-27 | Merck Sharp & Dohme | N-substituierte oxindolinderivate als calciumkanalblocker |
KR100985286B1 (ko) * | 2007-12-28 | 2010-10-04 | 주식회사 포스코 | 내지연파괴 특성이 우수한 고강도 고망간강 및 제조방법 |
EP2540295A1 (de) * | 2011-06-27 | 2013-01-02 | Centre national de la recherche scientifique | Zusammensetzungen zur Behandlung des Fragilen-X-Syndroms |
EP3288940B9 (de) | 2015-04-29 | 2021-07-21 | Janssen Pharmaceutica NV | Azabenimidazole und ihre verwendung als ampa-rezeptor-modulatoren |
US10604484B2 (en) * | 2015-04-29 | 2020-03-31 | Janssen Pharmaceutica Nv | Indolone compounds and their use as AMPA receptor modulators |
KR20190119602A (ko) | 2017-02-24 | 2019-10-22 | 오비드 테라퓨틱스 인크. | 발작 장애들을 치료하는 방법들 |
EP3889276A4 (de) * | 2019-01-25 | 2021-11-03 | JFE Steel Corporation | Verfahren zur herstellung von manganreichem stahlgussbrammen und verfahren zur herstellung von barren oder blechen aus manganreichem stahl |
CN110240558B (zh) * | 2019-07-10 | 2022-05-27 | 上海华理生物医药股份有限公司 | 一种Flindokalner消旋体的新合成方法 |
KR102209406B1 (ko) * | 2019-11-21 | 2021-01-29 | 주식회사 포스코 | 미세한 주조조직을 갖는 고망간강 및 그 제조방법과 이를 이용한 고망간 강판 |
EP3912625A1 (de) | 2020-05-20 | 2021-11-24 | Kaerus Bioscience Limited | Neuartige maxi-k-kaliumkanal-öffner zur behandlung von mit fragilem x assoziierten erkrankungen |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3114351A1 (de) * | 1981-04-09 | 1982-11-04 | Hoechst Ag, 6000 Frankfurt | "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung" |
DE3803775A1 (de) * | 1988-02-09 | 1989-08-17 | Boehringer Mannheim Gmbh | Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
US5200422A (en) * | 1990-09-24 | 1993-04-06 | Neurosearch A/S | Benzimidazole derivatives, their preparation and use |
NZ239540A (en) * | 1990-09-24 | 1993-11-25 | Neurosearch As | 1-phenyl benzimidazole derivatives and medicaments |
CZ279488B6 (cs) * | 1990-09-25 | 1995-05-17 | Lonza A.G. | Způsob mikrobiologické výroby hydroxylovaných heterocyklů |
US5234947A (en) * | 1991-11-07 | 1993-08-10 | New York University | Potassium channel activating compounds and methods of use thereof |
FR2714378B1 (fr) * | 1993-12-24 | 1996-03-15 | Sanofi Sa | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. |
-
1995
- 1995-06-07 US US08/477,047 patent/US5565483A/en not_active Expired - Lifetime
-
1996
- 1996-04-19 US US08/635,316 patent/US5602169A/en not_active Expired - Lifetime
- 1996-05-09 CA CA2176183A patent/CA2176183C/en not_active Expired - Fee Related
- 1996-05-18 TW TW085105918A patent/TW384284B/zh not_active IP Right Cessation
- 1996-05-21 IL IL11834996A patent/IL118349A/xx not_active IP Right Cessation
- 1996-05-28 ZA ZA9604327A patent/ZA964327B/xx unknown
- 1996-05-31 NO NO962232A patent/NO304829B1/no not_active IP Right Cessation
- 1996-06-04 CZ CZ19961618A patent/CZ289248B6/cs not_active IP Right Cessation
- 1996-06-05 NZ NZ286748A patent/NZ286748A/en not_active IP Right Cessation
- 1996-06-06 AU AU54757/96A patent/AU707760B2/en not_active Ceased
- 1996-06-06 AT AT96304188T patent/ATE195515T1/de not_active IP Right Cessation
- 1996-06-06 DE DE69609772T patent/DE69609772T2/de not_active Expired - Lifetime
- 1996-06-06 RU RU96111002/04A patent/RU2165925C2/ru not_active IP Right Cessation
- 1996-06-06 EP EP96304188A patent/EP0747354B1/de not_active Expired - Lifetime
- 1996-06-06 ES ES96304188T patent/ES2148685T3/es not_active Expired - Lifetime
- 1996-06-06 AR ARP960102970A patent/AR004493A1/es unknown
- 1996-06-06 HU HU9601547A patent/HU222046B1/hu not_active IP Right Cessation
- 1996-06-06 DK DK96304188T patent/DK0747354T3/da active
- 1996-06-06 PT PT96304188T patent/PT747354E/pt unknown
- 1996-06-07 SG SG1996010008A patent/SG70572A1/en unknown
- 1996-06-07 KR KR1019960020225A patent/KR100432157B1/ko not_active IP Right Cessation
- 1996-06-07 PL PL96314672A patent/PL184660B1/pl not_active IP Right Cessation
- 1996-06-07 CN CN96106834A patent/CN1076348C/zh not_active Expired - Fee Related
- 1996-06-07 JP JP14526396A patent/JP4011135B2/ja not_active Expired - Fee Related
-
1997
- 1997-03-20 BR BR1100180-1A patent/BR1100180A/pt active IP Right Grant
-
1998
- 1998-03-23 HK HK98102434A patent/HK1003301A1/xx not_active IP Right Cessation
-
2000
- 2000-09-29 GR GR20000402213T patent/GR3034523T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69609772D1 (de) | 3-Substituierte Oxindolderivate als Kaliumkanalmodulatoren | |
ATE354569T1 (de) | 3-substituierte-4-arylchinolin-2-on derivate als kaliumkanal- modulatoren | |
DE69610822T2 (de) | Indolderivate als 5-ht rezeptorantagoniste | |
DE69723446D1 (de) | Oxindole derivate | |
BR9611834A (pt) | Derivados de oximetóxi-3-aril-pirona | |
DE69841138D1 (de) | Imidazolderivate als mdr-modulatoren | |
ATE258054T1 (de) | 4-aryl-3-hydroxychinolin-2-on-derivate als modulatoren des ionenkanals | |
EP1011677A4 (de) | 4-aryl-3-aminoquinolin-2-one derivaten als kalium kanal modulatoren | |
BR9610597A (pt) | Derivados de diarilalcenilamina | |
ATE193701T1 (de) | Substituierte indol-derivate | |
AU6370196A (en) | Indole derivatives | |
NO975811D0 (no) | Ny anvendelse for pyrrolderivater | |
ATE210117T1 (de) | Indolderivate als melatoninanaloge | |
BR9610858A (pt) | Sal de pirrolidinil metil indol | |
DE59605373D1 (de) | Substituierte Indol-Derivate | |
AU6370096A (en) | Indole derivatives | |
AU6370296A (en) | Indole derivatives | |
KR970001583U (ko) | 트럭 텍크용 리어 포스트 | |
ITMI950030A0 (it) | Composti indolici | |
ITMI951687A0 (it) | Composti indolici |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |